Teva offers aggressive steering for progressive medicine
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) held an "Innovation and Technique Day" at present, by which it ...
Tag: Teva
Teva to put off an estimated 250-300 staff in Israel
Final week Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) printed its first quarter outcomes for 2025 and unexpectedly ...
Prilenia indicators deal for former Teva ALS drug value as much as 500m
Israeli-Dutch scientific stage biotech firm Prilenia Therapeutics has introduced a collaboration and licensing settlement for its lead drug Pridopidine, ...
Teva CEO responds to 25% share value fall
Since publishing its monetary outcomes for 2024 on the finish of January, the share value of Teva Pharmaceutical Industries ...
Teva jumps sharply on bowel illness drug outcomes
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA share value opened 20% increased on Wall Road after the Israeli ...
Teva experiences sturdy Q2 outcomes, raises 2024 forecast
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) reported sturdy outcomes for the second quarter of 2024 and once ...
Teva enlarges workforce for first time since 2016
For the primary time since 2016, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) enlarged its workforce throughout 2023. ...
Analysts bullish on Teva – Globes
An increasing number of analysts are expressing confidence within the inventory of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: ...
Teva buys rights for Israeli co Biolojic’s bronchial asthma therapy
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Israeli firm Biolojic Design have signed a collaboration settlement. Teva ...
Teva seeks to reinvent itself as branded drug developer
Again when Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) was recovering from its disastrous $40 billion acquisition of ...
